Effect of Sildenafil on Coronary Slow Flow Phenomeno

Phase 2

• Conditions: Coronary Slow Flow Phenomenon.; Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris; I25.118

• Registration Number: IRCT20220223054103N1
• Lead Sponsor: Yazd University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 25 July 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Patients with definitive diagnosis of CSFP on coronary angiography.
Patients with clinical signs of ischemia including typical angina pectoris (at least 2-3 minutes retrosternal and compressive angina) or dyspnea (equivalent to angina).

Exclusion Criteria

Patients with myocardial infarction or PCI or CABG or valve replacement or valve repair
Patients with Obstructive CAD (stenoses greater than 40%)
Patients with hepatic or renal failure or CVA or COPD or Cancer or acute infectious disease such as Covid 19
Patients older than 75 years or less than 30 years
Patients with low systolic blood pressure (<90 mmHg)
Patients with severe uncontrolled hypertension (> 180/100)
Patients with LVEF <50%

Study & Design

• Study Type: interventional
• Study Design: Not specified